至今,GenScript的服务及产品已被Cell, Nature, Science, PNAS等1300多家生物医药类杂志引用近万次,处于行业领先水平。NIH、哈佛、耶鲁、斯坦福、普林斯顿、杜克大学等约400家全球著名机构使用GenScript的基因合成、多肽服务、抗体服务和蛋白服务等成功地发表科研成果,再次证明GenScript 有能力帮助业内科学家Make research easy.

Adaptation and application of a two-plasmid inducible CRISPR-Cas9 system in Clostridium beijerinckii.

Methods. 2019; 
DialloMamou,HocqRémi,CollasFlorent,ChartierGwladys,WaselsFran?ois,WijayaHani Surya,WertenMarc W T,WolbertEmil J H,KengenServé W M,van der OostJohn,FerreiraNicolas Lopes,López-ContrerasA
Products/Services Used Details Operation
PCR Cloning and Subcloning Therefore, to simultaneously 9 JOURNAL PRE-PROOF address both matters, a BsaI/XcmI fragment encompassing the relevant regions was replaced with an accordingly designed synthetic BsaI/XcmI fragment (Genscript). Get A Quote

摘要

Recent developments in CRISPR technologies have opened new possibilities for improving genome editing tools dedicated to the Clostridium genus. In this study we adapted a two-plasmid tool based on this technology to enable scarless modification of the genome of two reference strains of Clostridium beijerinckii producing an Acetone/Butanol/Ethanol (ABE) or an Isopropanol/Butanol/Ethanol (IBE) mix of solvents. In the NCIMB 8052 ABE-producing strain, inactivation of the SpoIIE sporulation factor encoding gene resulted in sporulation-deficient mutants, and this phenotype was reverted by complementing the mutant strain with a functional spoIIE gene. Furthermore, the fungal cellulase-encoding celA gene was inse... More

关键词

CRISPR-Cas9,Clostridium beijerinckii,Genome editing,Nucl